Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain

Our objective was to assess the 5-year cost effectiveness of bronchodilator therapy with tiotropium, salmeterol or ipratropium for chronic obstructive pulmonary disease (COPD) from the perspective of the Spanish National Health System (NHS). A probabilistic Markov model was designed wherein patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Rutten-van Mölken, Maureen P. M. H., Oostenbrink, Jan B., Miravitlles, Marc, Monz, Brigitta U.
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2007
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913175/
https://www.ncbi.nlm.nih.gov/pubmed/17370096
http://dx.doi.org/10.1007/s10198-007-0039-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1913175/
https://www.ncbi.nlm.nih.gov/pubmed/17370096
http://dx.doi.org/10.1007/s10198-007-0039-4

Ejemplares similares